• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Online pharmacy boasts $55.4 million in sales

January 1, 2004
Jennifer Fiala

PetMed Express' financial statements reveal the online/mail-order pet pharmacy's revenues rose 91 percent to top out at $55.4 million from April to September last year, the Security and Exchange Commission (SEC) reports.

PetMed Express' financial statements reveal the online/mail-order pet pharmacy's revenues rose 91 percent to top out at $55.4 million from April to September last year, the Security and Exchange Commission (SEC) reports.

That compares to $29.1 million for the same fiscal period in 2002. Net income totaled $3.3 million, up from $1.1 million - a reflection of increased retail orders, SEC filings claim.

"The increase was primarily due to increased reorders and increased advertising, which was boosted by our free shipping promotion," company Chief Executive Officer Menderes Akdag explained to investors during a November telephone conference.

Advertisement

During the last six months, the pharmacy also has acquired 400,000 new customers, reports show. PetMed Express officials speculate that's largely due to the company's $4.8 million advertising campaign.

PetMed combats DVM competition

Still, veterinarians, not other pet pharmacies, continue to be PetMed Express' main competition, Akdag says.

"That's what we hear from our customer base or potential customers that contact us," he tells investors. "…There's no major competition in our category at this time. We're competing with veterinarians."

When an investor raises concerns about veterinarians matching PetMed Express prices, Akdag points to convenience and price control as customer draws. It's also why the company enacted the free shipping promotion for orders exceeding $49, he adds.

Taking fines in stride

As for litigation and fines concerning the alleged illegal distribution of prescription drugs that have plagued the company since its 1996 inception, PetMed Express officials claim that's routine and incidental to the business.

"The company's management does not believe that the resolution of any or all of such routine litigation and regulatory complaints are likely to have a material adverse effect on the company's financial condition or results of operations," an SEC report says.

The company rallies around its "powerful" brand name and "dramatic growth model," Akdag says.

PetMed Express' next move is to gain a NASDAQ listing, he adds.


Advertisement

Latest News

The four-letter word to why you're burning out and feeling unproductive

Merck Manuals recognizes importance of One Health concept

Topical therapy and immunotherapy can save time and frustration with dermatology cases

Texas Tech appoints new faculty member with passion for animal agriculture

View More Latest News
Advertisement